The European Journal of Health Economics 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Country-level effects of diagnosis-related groups: evidence from Germany ’s comprehensive reform of hospital payments
This study examined the uniquely comprehensive introduction of diagnosis-related groups (DRGs) in Germany, where DRGs function as the sole pricing, billing, and budgeting system for hospitals and almost exclusively determine hospital revenue. The introduction of DRGs, therefore, completely overhauled the previous system based on per diem rates, offering a unique opportunity for analysis. Using aggregate data from the Organisation for Economic Co-operation and Development and recent advances in econometrics, we analyzed how hospital activity and efficiency changed in response to the reform. We found that DRGs in Germany sig...
Source: The European Journal of Health Economics - December 5, 2023 Category: Health Management Source Type: research
Bayesian cost-effectiveness analysis of Whole genome sequencing versus Whole exome sequencing in a pediatric population with suspected genetic disorders
AbstractGenetic diseases are medical conditions caused by sequence or structural changes in an individual ’s genome. Whole exome sequencing (WES) and whole genome sequencing (WGS) are increasingly used for diagnosing suspected genetic conditions in children to reduce the diagnostic delay and accelerating the implementation of appropriate treatments. While more information is becoming available on clin ical efficacy and economic sustainability of WES, the broad implementation of WGS is still hindered by higher complexity and economic issues. The aim of this study is to estimate the cost-effectiveness of WGS versus WES and...
Source: The European Journal of Health Economics - November 17, 2023 Category: Health Management Source Type: research
Special FDA designations for drug development: orphan, fast track, accelerated approval, priority review, and breakthrough therapy
ConclusionSpecial FDA designations shorten clinical development and FDA approval times for new drugs treating rare and severe diseases with unmet medical needs. Special-designated drugs offer a greater clinical benefit to patients. However, physicians, patients, and insurers must be aware that special-designated drugs are often approved based on non-robust trials, associated with more unrecognized side effects, and sold for higher prices. (Source: The European Journal of Health Economics)
Source: The European Journal of Health Economics - November 14, 2023 Category: Health Management Source Type: research
Healthcare information management and operational cost performance: empirical evidence
AbstractHealthcare knowledge management systems can mitigate hospitals ’ operational inefficiency. As a healthcare information technology, the electronic health record (EHR) receives much attention from medical institutions due to its considerable impact on operational cost performance. This paper focuses on EHR systems to address operational inefficiency by which pa tients pay more for health care services, and many U.S. hospitals are filing for bankruptcy. From the theoretical perspective of the practice-based view, this paper introduces a path to implement EHR systems for improving cost performance. The empirical inve...
Source: The European Journal of Health Economics - November 11, 2023 Category: Health Management Source Type: research
New evidence on supplier-induced demand in China ’s public tertiary hospitals: is the cost of hospitalization higher in the off-season?
This study, therefore, aims to add new evidence on SID in China’s public tertiary hospitals and facilitates the development of evidence-based health policies in China and other countries with similar h ealthcare systems. For this study, we used patient-level electronic medical records (EMRs) collected from the information systems of tertiary hospitals in a western province in China. From 11 tertiary hospitals, we collected 274,811 hospitalization records dated between 15 February and 30 November 2 019. Total expenditure on hospitalization and length of admission of each patient were the primary metrics for measuring SID....
Source: The European Journal of Health Economics - November 3, 2023 Category: Health Management Source Type: research
How can health technology assessment be improved to optimise access to medicines? Results from a Delphi study in Europe
ConclusionsOur results reiterate that increased transparency during HTA and the decision-making processes is essential; the use of and reliance on new evidence generation such as real-world evidence can optimise the availability of medicines; and better collaborations between regulatory institutions within and between countries are paramount for better access to medicines. (Source: The European Journal of Health Economics)
Source: The European Journal of Health Economics - November 2, 2023 Category: Health Management Source Type: research
How do family doctors respond to reduced waiting times for cancer diagnosis in secondary care?
AbstractReducing waiting times is a priority in public health systems. Efforts of healthcare providers to shorten waiting times could be negated if they simultaneously induce substantial increases in demand. However, separating out the effects of changes in supply and demand on waiting times requires an exogenous change in one element. We examine the impact of a pilot programme in some English hospitals to shorten waiting times for urgent diagnosis of suspected cancer on family doctors ’ referrals. We examine referrals from 6,666 family doctor partnerships to 145 hospitals between 1st April 2012 and 31st March 2019. Five...
Source: The European Journal of Health Economics - October 3, 2023 Category: Health Management Source Type: research
